Status:
COMPLETED
EMINEM: Efficacy of Muscoril In NEck Myofascial Syndromes
Lead Sponsor:
Sanofi
Conditions:
Myofascial Pain Syndromes
Eligibility:
All Genders
18-50 years
Phase:
PHASE4
Brief Summary
Study objective: * To demonstrate, in patients with myofascial pain syndrome in cervical region, the degree of efficacy of thiocolchicoside ointment administered to trigger point regions compared wit...
Eligibility Criteria
Inclusion
- Submitted to clinic with a complaint of head and neck pain
- Be diagnosed as having myofascial pain syndrome by determining the active trigger points in trapezius and/or interscapular region according to criteria of Simons and Travel
- Have 1 to 8 active trigger point(s)
Exclusion
- Have evident cervical discopathy and signs of osteoarthritis
- Have bleeding diathesis or using anticoagulant medication which hinders injection
- Have known malignity, being used steroids, have immunodepressive disorders and/or being taken immunodepressive drugs
- Be pregnant or have the possibility of being pregnant or not being used a regular contraceptive method
- Have known allergic reaction against Thiocolchicoside
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00272532
Start Date
April 1 2005
Last Update
February 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis
Istanbul, Turkey (Türkiye)